Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, April 26, 2025

One-Year Outcome After Endovascular Thrombectomy for Basilar Artery Occlusion With Mild Deficits

 Your favorable functional outcome (a modified Rankin Scale score of 0–3) is still a COMPLETE FUCKING FAILURE! Survivors expect 100% recovery and you're not measuring that! GET THERE! YOU need to rid the stroke medical world of all these incompetent persons!

Well, since no one is measuring 100% recovery, you'll never get there.

The latest useless shit here:

One-Year Outcome After Endovascular Thrombectomy for Basilar Artery Occlusion With Mild Deficits

Yingjie Xu, MD https://orcid.org/0000-0002-4181-7450, Lulu Xiao, PhD https://orcid.org/0000-0002-5942-0902, Pan Zhang, MD https://orcid.org/0000-0001-6320-6987, Weiliang Shi, PhD, Shidong Tan, PhD, Miaomiao Hu, MD https://orcid.org/0009-0006-1821-0534, Zhanglin Li, MD https://orcid.org/0009-0001-6813-8589, … Show All … , and Wen Sun, PhD https://orcid.org/0000-0002-7268-2085 sunwen_medneuro@163.comAuthor Info & Affiliations
Stroke
New online
https://doi.org/10.1161/STROKEAHA.124.050389

  • Abstract

    BACKGROUND:

    The long-term benefits of endovascular thrombectomy (EVT) for basilar artery occlusion (BAO) in patients with low National Institutes of Health Stroke Scale scores upon admission remain unclear. This study aimed to compare the 1-year clinical follow-up outcomes of best medical management (BMM) alone versus BMM plus EVT.

    METHODS:

    Patients with BAO and admission National Institutes of Health Stroke Scale score of ≤10 at 65 stroke centers in China from December 2015 to June 2022 were retrospectively enrolled. The primary outcome was favorable functional outcome (a modified Rankin Scale score of 0–3 at 1 year). Early (door-to-puncture time ≤120 minutes) and late EVT (door-to-puncture time >120 minutes) classifications were defined as surrogates for comparing initial treatment with EVT versus late (potentially rescue) EVT after initially being treated with BMM only. Multivariable logistic regression and propensity score matching analyses were used to assess the association between treatment and outcomes.

    RESULTS:

    Among 1232 patients who had 1-year follow-up data, 856 (69.5%) were male, and the mean (SD) age was 65 (12) years. After adjustment for confounders, there were no significant differences between EVT and BMM in favorable functional outcome (odds ratio, 0.96 [95% CI, 0.71–1.29]; P=0.778). The cumulative 1-year mortality rate was 16.4% in the EVT group versus 13.7% in the BMM group (odds ratio, 1.23 [95% CI, 0.86–1.77]; P=0.262). Predefined subgroup analyses revealed that late EVT was inferior to early EVT (odds ratio, 0.47 [95% CI, 0.28–0.79]; P=0.005), while no significant difference was observed between BMM and early EVT in 1-year outcomes (odds ratio, 0.87 [95% CI, 0.63–1.21]; P=0.421).

    CONCLUSIONS:

    In this long-term follow-up study among patients with BAO admitted with a National Institutes of Health Stroke Scale score of ≤10, there were no significant differences in functional outcomes and mortality at 1 year between BMM plus EVT and BMM alone.

    Graphical Abstract

    Get full access to this article

    Posted by at
    Labels: , , , , , , ,

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)